These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27830531)

  • 1. Treatment of Severe Pain and Opioid-induced Constipation: An Observational Study of Quality of Life, Resource Use, and Costs in Sweden.
    Hjalte F; Ragnarson Tennvall G; Welin KO; Westerling D
    Pain Ther; 2016 Dec; 5(2):227-236. PubMed ID: 27830531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a fixed-dose opioid agonist/antagonist on constipation in patients on long-term opioids for non-malignant pain unable to tolerate laxatives.
    Mehta V; Alaward S; Kuravinakop S; Nikolic S
    Pain Physician; 2014; 17(5):415-24. PubMed ID: 25247899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone.
    Morlion B; Clemens KE; Dunlop W
    Clin Drug Investig; 2015 Jan; 35(1):1-11. PubMed ID: 25479959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].
    van Dongen VC; Vanelderen PJ; Koopmans-Klein G; van Megen YJ; Van Zundert J; Huygen FJ
    Int J Clin Pract; 2014 Nov; 68(11):1364-75. PubMed ID: 24853258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
    Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
    Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.
    Koopmans-Klein G; Van Op den Bosch J; van Megen Y; Prenen H; Huygen F; Mancini I
    Curr Med Res Opin; 2017 Dec; 33(12):2217-2227. PubMed ID: 28805471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study.
    Hesselbarth S; Löwenstein O; Cegla T
    Scand J Pain; 2014 Apr; 5(2):75-81. PubMed ID: 29913668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials.
    Blagden M; Hafer J; Duerr H; Hopp M; Bosse B
    Neurogastroenterol Motil; 2014 Dec; 26(12):1792-801. PubMed ID: 25346155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.
    Goeree R; Goeree J
    J Med Econ; 2016; 19(3):277-91. PubMed ID: 26535790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis.
    Dunlop W; Uhl R; Khan I; Taylor A; Barton G
    J Med Econ; 2012; 15(3):564-75. PubMed ID: 22313329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-Induced Constipation Relief From Fixed-Ratio Combination Prolonged-Release Oxycodone/Naloxone Compared With Oxycodone and Morphine for Chronic Nonmalignant Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Huang L; Zhou JG; Zhang Y; Wang F; Wang Y; Liu DH; Li XJ; Lv SP; Jin SH; Bai YJ; Ma H
    J Pain Symptom Manage; 2017 Nov; 54(5):737-748.e3. PubMed ID: 28736104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study.
    Bantel C; Tripathi SS; Molony D; Heffernan T; Oomman S; Mehta V; Dickerson S
    Clin Exp Gastroenterol; 2018; 11():57-67. PubMed ID: 29416370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation.
    Leppert W; Zajaczkowska R; Wordliczek J
    Expert Opin Pharmacother; 2019 Apr; 20(5):511-522. PubMed ID: 30625013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
    Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O
    Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments in managing severe chronic pain: role of oxycodone-naloxone extended release.
    Fanelli G; Fanelli A
    Drug Des Devel Ther; 2015; 9():3811-6. PubMed ID: 26229442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-induced constipation in chronic pain: Experience with 180 patients.
    Velázquez Rivera I; Velázquez Clavarana L; García Velasco P; Melero Ramos C
    J Opioid Manag; 2019; 15(1):69-76. PubMed ID: 30855724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-induced constipation in mixed chronic pain patients: Prevalence and predictors analysis.
    Samolsky Dekel BG; Sorella MC; Vasarri A; Gori A; Melotti RM
    J Opioid Manag; 2019; 15(5):375-387. PubMed ID: 31849029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ENhANCE trial protocol: A multi-centre, randomised, phase IV trial comparing the efficacy of oxycodone/naloxone prolonged release (OXN PR) versus oxycodone prolonged release (Oxy PR) tablets in patients with advanced cancer.
    Wong AK; Grobler A; Le B
    Contemp Clin Trials Commun; 2022 Dec; 30():101036. PubMed ID: 36407843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Prolonged-Release Oxycodone/Naloxone for Managing Pain and Opioid-Induced Constipation: A Review of the Evidence.
    Morlion BJ; Mueller-Lissner SA; Vellucci R; Leppert W; Coffin BC; Dickerson SL; O'Brien T
    Pain Pract; 2018 Jun; 18(5):647-665. PubMed ID: 28944983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.